Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANOS2P (Anosmin 2, pseudogene) is a transcribed but non-functional pseudogene on the Y chromosome, formerly known as KAL-Y or KALP. It is a degraded homolog of the X-linked *ANOS1* gene, which encodes anosmin-1, a protein involved in neuronal development and associated with X-linked Kallmann syndrome. ANOS2P contains frameshift and premature stop codons that render it non-coding and non-functional as a protein product. Current nomenclature (endorsed by HGNC) is intended to clearly distinguish this pseudogene from the functional *ANOS1*, which is a gene of clinical and biological significance. ANOS2P is not a receptor, enzyme, transporter, transcription factor, or any other class of functional therapeutic target. Its mention typically arises in genetic and evolutionary studies rather than drug discovery or clinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anosmin 2, pseudogene (ANOS2P).